Early heart attack drug could slash repeat cardiac events
NCT ID NCT07208006
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 33 times
Summary
This study tests whether giving a PCSK9 inhibitor (a powerful cholesterol-lowering drug) very early in the hospital, along with standard care, can reduce the risk of major heart problems like death, another heart attack, or stroke over the next year. About 1,500 adults who recently had a heart attack and have blockages in multiple heart arteries will take part. The goal is to see if this early treatment helps stabilize dangerous plaques and improves outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongshan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.